Back to search
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Clinicaltrials.gov:
EU CTIS:
#2023-507142-83-00
EudraCT:
J&J ID:
#CR108499
Other:
#CNTO148UCO3003
Subscribe or share this trial
Trials at a glance
Status
Enrollment complete
Condition
Colitis, Ulcerative
Trial type
Interventional
Trial phase
Phase 3
Investigational
product
product
Golimumab
Infliximab
Age
2 to 17 years old
Biological sex
All
Placebo?
No
Trial start date
October 29, 2018
Trial end date
February 1, 2027
CT.gov ID
#NCT03596645
Countries:
- Belgium,
- Brazil,
- France,
- Israel,
- Italy,
- Netherlands,
- Poland,
- South Korea,
- Spain,
- Taiwan,
- United States
Loading...
Florence, Italy, 50139
Messina, Italy, 98124
Roma, Italy, 00161
Seoul, South Korea, 05505
Rishon LeZiyyon, Israel, 70300
Bologna, Italy, 40133
São Paulo, Brazil, 01236030
San Giovanni Rotondo, Italy, 71013
Warsaw, Poland, 00 635
Taoyuan City, Taiwan, 33305
Atlanta, Georgia, United States, 30342
Aurora, Colorado, United States, 80045
Dallas, Texas, United States, 75207
Brussels, Belgium, 1200
New York, New York, United States, 10032
Hartford, Connecticut, United States, 06106
Fort Worth, Texas, United States, 76104
Garland, Texas, United States, 75044
Amsterdam, Netherlands, 1105 AZ
Knoxville, Tennessee, United States, 37922
Bordeaux, France, 33000
Málaga, Spain, 29011
Madrid, Spain, 28036
Madrid, Spain, 28009
Barcelona, Spain, 08950
Madrid, Spain, 28041
Barakaldo, Spain, 48902
Seville, Spain, 41013
Curitiba, Brazil, 80250-060
Paris, France, 75015
Trieste, Italy, 34137
Roma, Italy, 00165
Porto Alegre, Brazil, 90035-074
Zwolle, Netherlands, 8000 GK
Rzeszów, Poland, 35-302
Daegu, South Korea, 41404
Blumenau, Brazil, 89010-506
Rochester, Minnesota, United States, 55905
Taipei, Taiwan, 100
Wilmington, Delaware, United States, 19803
Haifa, Israel, 3109601
Lone Tree, Colorado, United States, 80124
Seoul, South Korea, 06351
Petah Tikva, Israel, 4920235
Seoul, South Korea, 03080
Seoul, South Korea, 03722
Jerusalem, Israel, 91031
Ramat Gan, Israel, 52621
Tel Aviv, Israel, 6997801
Warsaw, Poland, 04-730
Bydgoszcz, Poland, 85 094
Gdansk, Poland, 80 803
Taipei, Taiwan, 112
Jette, Belgium, 1090
Brussels, Belgium, 1020
San Francisco, California, United States, 94158
Krakow, Poland, 30 663
Olsztyn, Poland, 10 561
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Individual sites
Access detailed information on the trial:
Clinical trials information
© Johnson & Johnson and its affiliates 2026
